Ilia I. Ouspenski

Array ( [id] => 5106554 [patent_doc_number] => 20070065431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'V-like domain binding molecules' [patent_app_type] => utility [patent_app_number] => 11/588966 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11780 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20070065431.pdf [firstpage_image] =>[orig_patent_app_number] => 11588966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5210023 [patent_doc_number] => 20070248607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'NEGATIVE IMMUNOMODULATION OF IMMUNE RESPONSES BY NKG2D-POSITIVE CD4+ CELLS' [patent_app_type] => utility [patent_app_number] => 11/553327 [patent_app_country] => US [patent_app_date] => 2006-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 31360 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20070248607.pdf [firstpage_image] =>[orig_patent_app_number] => 11553327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5252784 [patent_doc_number] => 20070134240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Use of a CD28 binding substance for making a pharmaceutical composition' [patent_app_type] => utility [patent_app_number] => 11/585484 [patent_app_country] => US [patent_app_date] => 2006-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 6816 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134240.pdf [firstpage_image] =>[orig_patent_app_number] => 11585484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5040239 [patent_doc_number] => 20070092521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'ANTIBODY-BASED THERAPEUTICS WITH ENHANCED ADCC ACTIVITY' [patent_app_type] => utility [patent_app_number] => 11/551679 [patent_app_country] => US [patent_app_date] => 2006-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 12333 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092521.pdf [firstpage_image] =>[orig_patent_app_number] => 11551679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5068933 [patent_doc_number] => 20070190034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Immunomodulation using placental stem cells' [patent_app_type] => utility [patent_app_number] => 11/580588 [patent_app_country] => US [patent_app_date] => 2006-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 34197 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190034.pdf [firstpage_image] =>[orig_patent_app_number] => 11580588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4675583 [patent_doc_number] => 20080213212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Sialoadhesin factor-2 antibodies' [patent_app_type] => utility [patent_app_number] => 11/546586 [patent_app_country] => US [patent_app_date] => 2006-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13104 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213212.pdf [firstpage_image] =>[orig_patent_app_number] => 11546586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 278115 [patent_doc_number] => 07557191 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-07 [patent_title] => 'Sialoadhesin factor-2 antibodies' [patent_app_type] => utility [patent_app_number] => 11/546587 [patent_app_country] => US [patent_app_date] => 2006-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13101 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/557/07557191.pdf [firstpage_image] =>[orig_patent_app_number] => 11546587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5130762 [patent_doc_number] => 20070207159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Compositions and methods for enhancing antigen-specific immune response' [patent_app_type] => utility [patent_app_number] => 11/529956 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15433 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20070207159.pdf [firstpage_image] =>[orig_patent_app_number] => 11529956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688630 [patent_doc_number] => 20070106068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'HUMAN CYTOKINE RECEPTOR' [patent_app_type] => utility [patent_app_number] => 11/534706 [patent_app_country] => US [patent_app_date] => 2006-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61368 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20070106068.pdf [firstpage_image] =>[orig_patent_app_number] => 11534706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960065 [patent_doc_number] => 20080274490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'PD-1, a receptor for B7-4, and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/519186 [patent_app_country] => US [patent_app_date] => 2006-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 59425 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274490.pdf [firstpage_image] =>[orig_patent_app_number] => 11519186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 307105 [patent_doc_number] => 07531170 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-05-12 [patent_title] => 'Methods of treating OX40 mediated recall immune responses and agents useful for identifying same' [patent_app_type] => utility [patent_app_number] => 11/518364 [patent_app_country] => US [patent_app_date] => 2006-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16624 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/531/07531170.pdf [firstpage_image] =>[orig_patent_app_number] => 11518364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 196772 [patent_doc_number] => 07638492 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-29 [patent_title] => 'Methods of upmodulating an immune response with non-activating forms of B7-4' [patent_app_type] => utility [patent_app_number] => 11/514328 [patent_app_country] => US [patent_app_date] => 2006-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 69 [patent_no_of_words] => 53510 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/638/07638492.pdf [firstpage_image] =>[orig_patent_app_number] => 11514328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4999345 [patent_doc_number] => 20070041979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Proteolysis resistant antibody preparations' [patent_app_type] => utility [patent_app_number] => 11/506219 [patent_app_country] => US [patent_app_date] => 2006-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11100 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20070041979.pdf [firstpage_image] =>[orig_patent_app_number] => 11506219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5106550 [patent_doc_number] => 20070065427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Agents that modulate immune cell activation and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/501392 [patent_app_country] => US [patent_app_date] => 2006-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25357 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20070065427.pdf [firstpage_image] =>[orig_patent_app_number] => 11501392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4476111 [patent_doc_number] => 07868140 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-11 [patent_title] => 'Human anti-B7RP1 neutralizing antibodies' [patent_app_type] => utility [patent_app_number] => 11/458260 [patent_app_country] => US [patent_app_date] => 2006-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 25898 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/868/07868140.pdf [firstpage_image] =>[orig_patent_app_number] => 11458260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 299731 [patent_doc_number] => 07537930 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-26 [patent_title] => 'Mammalian cell lines for increasing longevity and protein yield from a cell culture' [patent_app_type] => utility [patent_app_number] => 11/487215 [patent_app_country] => US [patent_app_date] => 2006-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 18394 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/537/07537930.pdf [firstpage_image] =>[orig_patent_app_number] => 11487215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5339480 [patent_doc_number] => 20090055944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'HUMAN MONOCLONAL ANTIBODIES TO BE PROGRAMMED DEATH LIGAND 1 (PD-L1)' [patent_app_type] => utility [patent_app_number] => 11/917727 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 43915 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20090055944.pdf [firstpage_image] =>[orig_patent_app_number] => 11917727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5850628 [patent_doc_number] => 20060233819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Inhibition of T cell activation by butyrophilin 4 or B7-L1' [patent_app_type] => utility [patent_app_number] => 11/477982 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 36277 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20060233819.pdf [firstpage_image] =>[orig_patent_app_number] => 11477982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4932450 [patent_doc_number] => 20080003225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-03 [patent_title] => 'Method for enhancing the antibody-dependent cellular cytotoxicity (ADCC) and uses of T cells expressing CD16 receptors' [patent_app_type] => utility [patent_app_number] => 11/477740 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14698 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20080003225.pdf [firstpage_image] =>[orig_patent_app_number] => 11477740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921367 [patent_doc_number] => 20060240010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Methods of modulating CD200 receptors' [patent_app_type] => utility [patent_app_number] => 11/478778 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11994 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240010.pdf [firstpage_image] =>[orig_patent_app_number] => 11478778 [rel_patent_id] =>[rel_patent_doc_number] =>)